An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2009
At a glance
- Drugs PRX 08066 (Primary)
- Indications Chronic obstructive pulmonary disease; Pulmonary hypertension
- Focus Therapeutic Use
- 31 Jul 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 May 2008 New trial record.